Daejeon
South Korea
13
2025-06-12
The entities that hold a legal rights for patent applications filed by inventor Park Jae Eun:
Jae Eun Park from Daejeon, KR has applied for patents for these inventions. The list has both pending applications and granted patents:
PD-L1-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND IMMUNE CELL COMPRISING SAME
#2 | 2025-01-16RESISTIN-SPECIFIC ANTIBODY AND USE THEREOF
#3 | 2024-05-16ANTI-VSIG4 ANTIBODY OR ANTIGEN BINDING FRAGMENT AND USES THEREOF
#4 | 2022-11-03ANTIBODY BINDING SPECIFICALLY TO B7-H3 AND USE THEREOF
#5 | 2022-10-27ANTIBODY-DRUG CONJUGATES THAT TARGET DLK1 AND USES THEREOF
#6 | 2022-09-29ANTI-VSIG4 ANTIBODY OR ANTIGEN BINDING FRAGMENT AND USES THEREOF
#7 | 2022-02-17Antibody-drug conjugates comprising anti-B7-H3 antibodies
#8 | 2021-08-05Monoclonal antibody specifically binding to LAG-3 and use thereof
#9 | 2019-10-24Antibody to programmed death-ligand 1 (PD-L1) and use thereof
#10 | 2019-08-15Antibody to programmed cell death 1 (PD-1) and use thereof
#11 | 2017-05-04Composition for preventing or treating fatty liver or insulin resistance syndrome including extracellular domain of delta-like 1 homolog
#12 | 2015-04-23Drug conjugate comprising drug linked to human c-Met antibody, and use therefor
#13 | 2015-01-29Myostatin inhibitor comprising extracellular water-soluble domains of DLK1 as active ingredient
1050836 ⎘